Boston Scientific And Angiotech Win Stent Suit
The Dutch court confirmed that the Canadian drug company’s patent was valid and Sahajanand’s Infinnium paclitaxel-eluting stent infringed on it. India-based Sahajanand has been ordered to pay for damages as a result of the infringement.
The court also permitted an injunction against Sahajanand, barring the company from selling or delivering...
To view the full article, register now.